My Quote Request
No products added yet
6505-01-353-1065
20 Products
NDC00338-0016-02
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013531065
NSN
6505-01-353-1065
NDC00338-0016-02
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013531065
NSN
6505-01-353-1065
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: NON VENTED GLASS BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
RELAFEN TABLETS
NABUMETONE TABLETS
NSN, MFG P/N
6505013529299
NSN
6505-01-352-9299
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NABUMETONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NABUMETONE TABLETS 500MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RELAFEN BY SMITHKLINE BEECHMAN PHARMACEUTICALS
Related Searches:
NDC00029-4851-21
NABUMETONE TABLETS
NSN, MFG P/N
6505013529300
NSN
6505-01-352-9300
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NABUMETONE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NABUMETONE TABLETS 500MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RELEFEN BY SMITHKLINE BEECHMAN PHARMACEUTICALS
Related Searches:
RELAFEN
NABUMETONE TABLETS
NSN, MFG P/N
6505013529300
NSN
6505-01-352-9300
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NABUMETONE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NABUMETONE TABLETS 500MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RELEFEN BY SMITHKLINE BEECHMAN PHARMACEUTICALS
Related Searches:
RELAFEN TABLETS
NABUMETONE TABLETS
NSN, MFG P/N
6505013529300
NSN
6505-01-352-9300
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NABUMETONE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NABUMETONE TABLETS 500MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RELEFEN BY SMITHKLINE BEECHMAN PHARMACEUTICALS
Related Searches:
ACCUPRIL
QUINAPRIL HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013529508
NSN
6505-01-352-9508
ACCUPRIL
QUINAPRIL HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013529508
NSN
6505-01-352-9508
MFG
WARNER-LAMBERT LLC DBA PFIZER DIV INSITITUIONAL SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS QUINAPRIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINAPRIL HYDROCHLORIDE TABLETS 40MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ACCUPRIL TABLETS
QUINAPRIL HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013529508
NSN
6505-01-352-9508
ACCUPRIL TABLETS
QUINAPRIL HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013529508
NSN
6505-01-352-9508
MFG
WARNER-LAMBERT LLC DBA PFIZER DIV INSITITUIONAL SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS QUINAPRIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINAPRIL HYDROCHLORIDE TABLETS 40MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00071-0535-23
QUINAPRIL HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013529508
NSN
6505-01-352-9508
NDC00071-0535-23
QUINAPRIL HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013529508
NSN
6505-01-352-9508
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS QUINAPRIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINAPRIL HYDROCHLORIDE TABLETS 40MG 90S BT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
A91J155
POLYMYXIN B SULFATE
NSN, MFG P/N
6505013529514
NSN
6505-01-352-9514
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 10000.000 UNITS POLYMYXIN,3.5 MG NEOMYCIN SULFATE,AND 1 PERCENT HYDROCORTISONE; 7.5 ML PER BOTTLE; PACKAGED WITH STERILIZED DROPPER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYMYXIN B SULFATE NEOMYCIN SULF & HYDROCORTISONE OTIC SUSP 7.5ML
Related Searches:
NDC61570-0038-75
POLYMYXIN B SULFATE
NSN, MFG P/N
6505013529514
NSN
6505-01-352-9514
MFG
MONARCH PHARMACEUTICALS INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 10000.000 UNITS POLYMYXIN,3.5 MG NEOMYCIN SULFATE,AND 1 PERCENT HYDROCORTISONE; 7.5 ML PER BOTTLE; PACKAGED WITH STERILIZED DROPPER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYMYXIN B SULFATE NEOMYCIN SULF & HYDROCORTISONE OTIC SUSP 7.5ML
Related Searches:
1A6013
FAT EMULSION INJECTION
NSN, MFG P/N
6505013529932
NSN
6505-01-352-9932
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 1.200 PERCENTAGE, V/V PHOSPHOLIPIDS ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH ADMINISTRATION SET; WITHOUT TUBING
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00338-0490-03
FAT EMULSION INJECTION
NSN, MFG P/N
6505013529932
NSN
6505-01-352-9932
NDC00338-0490-03
FAT EMULSION INJECTION
NSN, MFG P/N
6505013529932
NSN
6505-01-352-9932
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 1.200 PERCENTAGE, V/V PHOSPHOLIPIDS ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH ADMINISTRATION SET; WITHOUT TUBING
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
1A-00-62-UO
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013531065
NSN
6505-01-353-1065
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: NON VENTED GLASS BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
F91K158
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013531065
NSN
6505-01-353-1065
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: NON VENTED GLASS BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00005-3220-34
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013533046
NSN
6505-01-353-3046
NDC00005-3220-34
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013533046
NSN
6505-01-353-3046
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ATENOLOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1507-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013533046
NSN
6505-01-353-3046
NDC00781-1507-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013533046
NSN
6505-01-353-3046
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ATENOLOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC53489-0530-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013533046
NSN
6505-01-353-3046
NDC53489-0530-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013533046
NSN
6505-01-353-3046
MFG
MUTUAL PHARMACEUTICAL COMPANY INC. DBA URL PHARMA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ATENOLOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 100MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CARDURA
DOXAZOSIN MESYLATE TABLETS
NSN, MFG P/N
6505013533771
NSN
6505-01-353-3771
MFG
ROERIG DIV PFIZER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARDURA
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 MG
Related Searches:
CARDURA TABLETS
DOXAZOSIN MESYLATE TABLETS
NSN, MFG P/N
6505013533771
NSN
6505-01-353-3771
CARDURA TABLETS
DOXAZOSIN MESYLATE TABLETS
NSN, MFG P/N
6505013533771
NSN
6505-01-353-3771
MFG
ROERIG DIV PFIZER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARDURA
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 MG
Related Searches:
NDC00049-2750-66
DOXAZOSIN MESYLATE TABLETS
NSN, MFG P/N
6505013533771
NSN
6505-01-353-3771
NDC00049-2750-66
DOXAZOSIN MESYLATE TABLETS
NSN, MFG P/N
6505013533771
NSN
6505-01-353-3771
MFG
ROERIG DIV PFIZER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARDURA
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 MG
